enVVeno Medical (NVNO) Enterprise Value (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | enVVeno Medical | 6.99 Mn | 6.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.63% |
| Dec 31, 2025 | 8.85% |
| Sep 30, 2025 | 11.92% |
| Jun 30, 2025 | 9.76% |
| Mar 31, 2025 | 9.76% |
| Dec 31, 2024 | 10.80% |
| Sep 30, 2024 | -23.84% |
| Jun 30, 2024 | 9.02% |
| Mar 31, 2024 | 7.48% |
| Dec 31, 2023 | -80.61% |
| Sep 30, 2023 | 13.64% |
| Jun 30, 2023 | 55.01% |
| Mar 31, 2023 | -69.38% |
| Dec 31, 2022 | 3.18% |
| Sep 30, 2022 | -7.59% |
| Jun 30, 2022 | 26.99% |
| Mar 31, 2022 | 6.19% |
| Dec 31, 2021 | 5.47% |
| Sep 30, 2021 | -41.08% |
| Jun 30, 2021 | 6.38% |
| Mar 31, 2021 | -369.62% |
| Dec 31, 2020 | -65.83% |
| Sep 30, 2020 | -259.93% |
| Jun 30, 2020 | -117.17% |
| Mar 31, 2020 | 44.91% |
| Dec 31, 2019 | 55.59% |
| Sep 30, 2019 | 34.08% |
| Jun 30, 2019 | -62.23% |
| Mar 31, 2019 | -0.43% |
| Dec 31, 2018 | 34.58% |
| Sep 30, 2018 | 29.50% |
| Jun 30, 2018 | -1,822.31% |
| Mar 31, 2018 | -297.91% |
| Dec 31, 2017 | 75.06% |
| Sep 30, 2017 | -1,857.04% |